NRXP

NRX Pharmaceuticals, Inc.

0.43 USD
-0.01 (-1.30%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

NRX Pharmaceuticals, Inc. stock is down -1.3% since 30 days ago. The next earnings date is Mar 28, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 57.14% of the previous 6 February’s closed higher than January.

About NRX Pharmaceuticals, Inc.

NRX Pharmaceuticals, Inc. develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure.